Neogen director Rodriguez receives 20,558 stock options
The options and restricted stock units vest in equal annual installments on each of the first three grant anniversaries.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Neogen Corp. (NEOG) director Rafael A. Rodriguez received an award of rights to buy 20,558 common shares at an exercise price of $12.24, along with 9,804 restricted stock units, on October 1, 2026. The reported holdings after the awards were 20,558 rights to buy common stock and 30,625 restricted stock units. Both awards vest in equal annual installments on each of the first three anniversary dates of the grants; the rights to buy common stock expire October 1, 2036.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock (Right to Buy) F1 | 20,558 | $0.00 | $0.00 |
| Grant/Award | Restricted Stock Units F1 | 9,804 | $12.24 | $120K |
Footnotes (1)
- F1. Options and RSUs vest in equal annual installments on each of the first three anniversary dates of the grants
Key Figures
Key Terms
Restricted Stock Units financial
Right to Buy financial
exercise price financial
vest in equal annual installments financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did NEOG director Rafael A. Rodriguez receive?
How do Rafael A. Rodriguez's NEOG awards vest?
AI-generated analysis. How Rhea-AI works. Not financial advice.